Surgical Sutures Market Size, Share & Trend Analysis Report By Type (Absorbable, Non-Absorbable), By Filament (Monofilament, Multifilament), By Application, By Region, And Segment Forecasts, 2024 - 2030

Surgical Sutures Market Size & Trends

The global surgical sutures market size was estimated at USD 4.56 billion in 2023 and is expected to grow with a compound annual growth rate (CAGR) of 5.1% from 2024 to 2030. Several major factors are anticipated to drive the overall market growth during the forecast period. These include rising healthcare demands from an aging population, a surge in chronic diseases requiring surgical intervention, advancements in suture materials and techniques, and a heightened emphasis on minimally invasive procedures. For instance, the Global Survey 2022 by ISAPS states an 11.2% overall increase in procedures performed by plastic surgeons in 2022, with more than 14.9 million surgical and 18.8 million non-surgical procedures performed worldwide.

The COVID-19 pandemic led to a significant shift in healthcare priorities, focusing on treating infected patients and implementing strict lockdown measures. As a result, elective surgeries were postponed or stopped to reduce infection risks, leading to a decline in the demand for surgical sutures in 2020-21. However, as countries work towards reopening their economies and returning to normalcy, healthcare facilities rapidly resume surgical procedures. They are adopting innovative strategies such as telehealth assessments, screening tools, and streamlined coordination methods. Tactics like using mobile apps to provide information to surgeons and patients have improved healthcare operations, maximizing efficiency while ensuring patient care. These strategies, essential in compensating for pandemic-induced losses, have helped hospitals and surgical centers approach pre-COVID revenue levels, contributing to the resurgence of the market.

The rise in lifestyle diseases due to the increasing adoption of a sedentary lifestyle is another factor contributing to the growth of surgical sutures. Lifestyle diseases such as ischemic heart diseases, cerebrovascular diseases, orthopedic disorders, cancers, and mental illness are constantly rising globally. This continuous rise in the prevalence of lifestyle diseases demands more surgical procedures, leading to the market growth of surgical sutures.

The rise in healthcare expenditure by most countries and the improvement of healthcare infrastructure in emerging economies are expected to boost market growth. In addition, technological advancement by key players helps to initiate more precise procedures, which increases the success rate of surgery and also leads to the market growth of surgical sutures. In addition, the growing prevalence of chronic conditions requiring surgeries, coupled with technological innovations, and expanding healthcare infrastructures across regions, contributes significantly to the market's upward trajectory.

Market Concentration & Characteristics

The market growth stage is high, and the pace of the market growth is accelerating due to advancements in medical technology and materials used in sutures, which have led to enhanced product efficacy, driving product adoption and demand. Furthermore, the rising prevalence of chronic diseases and age-related ailments necessitating surgical interventions, coupled with a growing global population, contributes significantly to the expanding market.

The level of merger and acquisition (M&A) activity in the market is increasing as companies merge and acquire each other to increase their market share, offer a wider range of products, and gain access to innovative technologies and specialty materials for sutures. These mergers and acquisitions also allow companies to work together more effectively, run their businesses more efficiently, and improve their distribution networks, ultimately making them stronger competitors.

Regulations governing the surgical sutures market are overseen by health authorities and regulatory bodies within respective countries or regions. Agencies like the FDA in the U.S., the European Medicines Agency (EMA) in the European Union, and other analogous regulatory bodies globally play a crucial role in setting standards, monitoring, and approving surgical sutures. These regulatory entities ensure that sutures meet stringent safety, quality, and efficacy standards before being marketed and used in medical procedures.

Alternative methods for closing wounds are becoming more popular in the medical field. These methods serve the same purpose as traditional sutures, including adhesive tissue sealants, staples, tapes, and hemostats. Adhesive tissue sealants create a bond between tissue surfaces, reducing the need for traditional sutures in certain procedures. Staples are used instead of sutures for closing larger incisions or wounds, providing rapid closure but may cause more tissue trauma. These alternatives offer numerous benefits, such as being cost-effective, time-efficient, and producing optimal cosmetic results.

Companies in the market are looking to grow in new areas by teaming up with local distributors or manufacturers, forming strategic alliances, or establishing subsidiaries or offices in target regions. This expansion strategy allows them to reach untapped markets and exploit the increasing demand for surgical sutures. These partnerships and local connections can significantly facilitate international expansion by providing valuable insights into the target market, distribution channels, and customer preferences.

Application Insights

The cardiovascular surgery segment dominated the market in 2023 due to the high incidence of cardiac diseases, sufficient experts in the field, supportive reimbursement scenarios, and advanced diagnostics. For instance, according to the World Health Federation 2023 report, more than half a billion people around the world continue to be affected by cardiovascular diseases, which accounted for 20.5 million deaths in 2021 – close to a third of all deaths globally and an overall increase on the estimated 121 million CVD deaths. This significant rise in the number of cardiac surgeries, in turn, is leading to an increase in demand for surgical sutures over the forecast period.

The orthopedic surgery segment is expected to witness the fastest CAGR over the forecast period due to the increasing prevalence of orthopedic conditions, and advancements in orthopedic surgical procedures. These factors may lead to a higher demand for specialized sutures tailored for these surgeries. Increasing number of surgical procedures and the rising elderly population, often requiring orthopedic interventions, contribute to the market growth.

Regional Insights

North America accounted for the largest revenue share of nearly 43.7% in 2023 owing to the strong presence of major local and international companies, which led to the development of innovative products and extensive distribution networks. In addition, the relatively higher cost of sutures compared to other regions and supportive reimbursement policies and government healthcare programs created a favorable environment for sustained market growth. The region's well-established healthcare infrastructure also played a significant role in its dominance, allowing widespread access to advanced surgical techniques and contributing to its substantial market share within North America.

The U.S. accounted for North America's largest market share in 2023. This is due to strong healthcare infrastructure, extensive research and development activities, and the presence of major healthcare players and manufacturers within its borders. In addition, the U.S. healthcare system's emphasis on innovation, high healthcare expenditures, and favorable reimbursement policies further help its prominent share in the market.

Asia Pacific is expected to experience maximum growth during the forecast period due to the increasing number of geriatric population, which tends to require more surgical interventions. In addition, increased government investments in healthcare infrastructure across the Asia Pacific aim to address the region's unmet healthcare needs, further fostering the growth of the market. The largest population increase in chronic diseases demands surgical interventions, making the Asia Pacific region a promising market for surgical sutures.

Type Insights

The absorbable segment held the highest market share and is anticipate to grow at the fastest CAGR over the forecast period. The demand for absorbable sutures is continuously rising due to their ability to temporarily support wounds until they heal and can withstand normal stress. In addition, absorbable sutures can degrade naturally, making them a preferred choice. Many companies have launched new products, and some have received approval; for instance, in 2023, Genesis MedTech obtained approval from China's NMPA for the market release of its absorbable sutures with antibacterial protection. These absorbable sutures are designed to provide enhanced healing and reduce the risk of infection. Due to this, key players in the market are investing in R&D activities, which is further expected to help the absorbable segment in the future.

The non-absorbable segment is predicted to hold lucrative growth in the market due to its long-lasting nature and sustained demand for various surgical procedures. Their durability and effectiveness drive this rise in popularity, which helps contribute to their lucrative expansion within the market.

Filament Insights

The multifilament segment dominated the market with a significant revenue share and is expected to experience maximum growth during the forecast period. This can be attributed to advantages associated with multifilament, such as better compliance, high tensile strength, and flexibility.

Monofilament is showing lucrative growth in the market due to its single-strand design, which offers reduced tissue trauma and better handling characteristics during surgeries. The increasing preference for monofilament sutures is attributed to their decreased risk of infection and tissue reaction, contributing significantly to their expanding market share. However, monofilament sutures are difficult to manage and may cause crushing or crimping of the suture and lead to undesirable and premature suture failure during surgery due to memory. This factors restricts the growth of monofilament sutures

Key Companies & Market Share Insights

Some of the key players operating in the market include Medtronic, and Ethicon US, LLC. (Johnson & Johnson Services, Inc.), B. Braun Melsungen AG, Smith & Nephew, Integra Lifesciences, CONMED CORPORATION.

• Medtronic, is a leading global healthcare products company offering a wide range of medical devices, including surgical sutures, focusing on innovation and quality.

• Ethicon US, LLC. (Johnson & Johnson Services, Inc.): Ethicon, a subsidiary of Johnson & Johnson, is a manufacturer of surgical sutures and wound closure devices, known for its extensive portfolio and commitment to advancing surgical care.

• B. Braun focuses on providing various medical solutions, including surgical sutures, known for its high-quality products and commitment to improving patient outcomes through innovation

• Smith & Nephew specializes in orthopedics, wound management, and sports medicine, and offers a range of surgical sutures and wound closure products.

• Integra Lifesciences is one of the leading providers of surgical implants and medical instruments, offering innovative solutions in the surgical sutures segment, catering to neurosurgery, orthopedics, and wound closure.

• CONMED offers a wide array of surgical products, including sutures, aiming to provide innovative solutions to enhance patient care and surgical outcomes

• Peter Surgical, Internacional farmaceutica, and Sutures India Pvt. Ltd. are some of the emerging market players functioning in surgical sutures industry.

• Peter Surgical is one of the growing players in the surgical suture market, known for its range of surgical sutures and wound closure products, emphasizing quality and innovation in its offerings.

• Internacional farmaceutica is an emerging company focusing on healthcare products, including surgical sutures, striving to establish its presence in the market through quality products and expanding market reach.

• Sutures India Pvt. Ltd. is a manufacturer of surgical sutures, renowned for its diverse range of products, catering to various surgical needs and ensuring high-quality standards in the medical devices they produce.

Recent Developments

• In September 2023, Genesis MedTech secured approval from China's NMPA to launch antibacterial absorbable sutures, aiming to improve healing outcomes and lower infection risks in the market.

• In August 2023, Healthium Medtech, introduced TRUMAS, a specialized range of sutures tailored for challenges encountered during suturing in minimal access surgeries

• In May 2023, MIT engineers created advanced "smart" sutures resembling traditional "catgut" ones, equipped with sensors and capable of delivering drugs to detect inflammation at surgical sites. These innovative sutures, made from animal tissue and coated with hydrogels, hold the potential to embed therapeutic components like sensors, drugs, or cells for targeted medical applications.

• In January 2023, Able  Medical Devices announced the launch of Valkyrie looped sternotomy sutures. It is a stainless-steel looped wire suture used to approximate sternums.

• In December 2022, Stryker launched Citrefix, a suture anchor system designed for foot and ankle surgical procedures.

Surgical Sutures Market Report Scope

Global Surgical Sutures Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global surgical sutures market report based on type, filament, application, and region:

• Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Absorbable

  • Non-absorbable

• Filament Outlook (Revenue, USD Million, 2018 - 2030)

  • Monofilament

  • Multifilament

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Ophthalmic Surgery

  • Cardiac Surgery

  • Orthopedic Surgery

  • Neurological Surgery

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Norway

    • Sweden

    • Denmark

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait